Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death

Journal of the American Society of Hypertension

Volumn 2, Issue 5, 2008, Pages

  Hebert, Patricia R ^a   Coffey, Christopher S ^b   Byrne, Daniel W ^c   Scott, Theresa A ^c   Fagard, Robert H ^d   Rottman, Jeffrey N ^c   Murray, Katherine T ^c   Oates, John A ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

inhibitor hydrochlorothiazide; meta analysis; Potassium; ventricular tachyarrhythmia

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPITHELIAL SODIUM CHANNEL INHIBITOR; HYDROCHLOROTHIAZIDE; METHYLDOPA; METOPROLOL; NIFEDIPINE; PINDOLOL; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DATA COLLECTION METHOD; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; ELDERLY CARE; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SUDDEN DEATH; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 51549121186     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.04.001     Document Type: Article

References (40)

1. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N.H., Eberlein K.A., et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335 (1990) 827-838
2. Hoes A.W., Grobbee D.E., Lubsen J., Man in't Veld A.J., van der Does E., and Hofman A. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 123 (1995) 481-487
3. Siscovick D.S., Raghunathan T.E., Psaty B.M., Koepsell T.D., Wicklund K.G., Lin X., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330 (1994) 1852-1857
4. Garan H., McGovern B.A., Canzanello V.J., McCauley J., Bodvarsson M., Harrington J.T., et al. The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. Circulation 77 (1988) 696-704
5. Hohnloser S.H., Verrier R.L., Lown B., and Raeder E.A. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J 112 (1986) 32-35
6. Curtis M.J., and Hearse D.J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 21 (1989) 21-40
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304 (1992) 405-412
8. Amery A., Birkenhager W., Brixko P., Bulpitt C., Clement D., Deruyttere M., et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1 (1985) 1349-1354
9. Dahlof B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., and Wester P.O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 338 (1991) 1281-1285
10. Grobbee D.E., and Hoes A.W. Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens 13 (1995) 1539-1545
11. Hebert P.R., Moser M., Mayer J., Glynn R.J., and Hennekens C.H. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 153 (1993) 578-581
12. Psaty B.M., Lumley T., Furberg C.D., Schellenbaum G., Pahor M., Alderman M.H., and Weiss N.S. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289 (2003) 2534-2544
13. Staessen J.A., Gasowski J., Wang J.G., Thijs L., Den Hond E., Boissel J.P., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355 (2000) 865-872
14. Borhani N.O., Blaufox M.D., Oberman A., and Polk B.F. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 29 (1986) S55-S62
15. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 248 (1982) 1465-1477
16. Medical Research Council Working Party on Mild Hypertension. Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Br Heart J 59 (1988) 364-378
17. Smith W.M. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 40 (1977) I98-I105
18. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension. Ann N Y Acad Sci 304 (1978) 267-292
19. Coope J., and Warrender T.S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 293 (1986) 1145-1151
20. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202 (1967) 1028-1034
21. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1 (1980) 1261-1267
22. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213 (1970) 1143-1152
23. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 108 (1995) 710-717
24. Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial. Br Med J 3 (1973) 434-436
25. Carter A.B. Hypotensive therapy in stroke survivors. Lancet 1 (1970) 485-489
26. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 229 (1974) 409-418
27. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo Study. Am J Med 69 (1980) 725-732
28. Perry Jr. H.M., Smith W.M., McDonald R.H., Black D., Cutler J.A., Furberg C.D., et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke 20 (1989) 4-13
29. Bulpitt C.J., Beckett N.S., Cooke J., Dumitrascu D.L., Gil-Extremera B., Nachev C., et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 21 (2003) 2409-2417
30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
31. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
32. Egger M., Smith G., and Altman D. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd edition (2001), BMJ Publishing Co, London, England 146-47, 364
33. Altman D., Machin D., Bryant T., and Gardner M. Statistics with Confidence - Confidence Intervals and Statistical Guidelines. 2nd edition (2000), British Medical Journal, London, England
34. Saha C., Eckert G.J., Ambrosius W.T., Chun T.Y., Wagner M.A., Zhao Q., Pratt J.H., et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 46 (2005) 481-487
35. Burke A.P., Farb A., Malcom G.T., Liang Y., Smialek J.E., and Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281 (1999) 921-926
36. Davies M.J., and Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 310 (1984) 1137-1140
37. Spaulding C.M., Joly L.M., Rosenberg A., Monchi M., Weber S.N., Dhainaut J.F., and Carli P. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336 (1997) 1629-1633
38. Campbell S.E., Janicki J.S., Matsubara B.B., and Weber K.T. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride. Am J Hypertens 6 (1993) 487-495
39. Schatzkin A., Cupples L.A., Heeren T., Morelock S., and Kannel W.B. Sudden death in the Framingham Heart study. Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol 120 (1984) 888-899
40. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481